DSpace at RU >

Browsing by Author Wit, F.W.

Full Text	Issue Date	Title	Author(s)
	2011	Adherence to HIV therapeutic drug monitoring guidelines in The Netherlands	Luin, M. van; Wit, F.W.; Smit, C.; Rigter, I.M.; Franssen, E.J., et al
	2010	Lower atovaquone/proguanil concentrations in patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavir.	Luin, M. van; Ende, M.E. van der; Richter, C.; Visser, M. de; Faraj, D., et al
	2009	Efavirenz Dose Reduction Is Safe in Patients With High Plasma Concentrations and May Prevent Efavirenz Discontinuations	Luin, M. van; Gras, L.; Richter, C.; Ende, M.E. van der; Prins, J.M., et al
	2009	Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy.	Kesselring, A.M.; Wit, F.W.; Sabin, C.A.; Lundgren, J.D.; Gill, M.J., et al
	2008	Steady-state nevirapine plasma concentrations are influenced by pregnancy.	Nellen, J.F.; Damming, M.; Godfried, M.H.; Boer, K.; Ende, M.E. van der, et al
	2007	Ketoconazole is inferior to ritonavir as an alternative booster for saquinavir in a once daily regimen in Thai HIV-1 infected patients.	Autar, R.S.; Wit, F.W.; Sankote, J.; Sutthichom, D.; Kimenai, E., et al
	2007	Relationships between drug exposure, changes in metabolic parameters and body fat in HIV-infected patients switched to a nucleoside sparing regimen.	Autar, R.S.; Boyd, M.A.; Wit, F.W.; Ruxrungthams, K.; Sankote, J., et al
	2005	Nevirapine plasma concentrations and concomitant use of rifampin in patients coinfected with HIV-1 and tuberculosis.	Autar, S.R.; Wit, F.W.; Sankote, J.; Mahanontharit, A.; Anekthananon, T., et al
	2004	Nelfinavir plasma concentrations are low during pregnancy.	Nellen, J.F.; Schillevoort, I.; Wit, F.W.; Bergshoeff, A.S.; Godfried, M.H., et al